Screening of a series of 3,5-disubstituted 1,2,4-thiadiazoles for selectivity of cytotoxic action to cancer cells
- 27 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Russian Chemical Bulletin
- Vol. 70 (3), 510-514
- https://doi.org/10.1007/s11172-021-3116-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Current Screening Methodologies in Drug Discovery for Selected Human DiseasesMarine Drugs, 2018
- Cytotoxicity Test Based on Human Cells Labeled with Fluorescent Proteins: Fluorimetry, Photography, and Scanning for High-Throughput AssayMolecular Imaging & Biology, 2017
- 1,2,4-Thiadiazole derivatives as effective NMDA receptor blockers with anticholinesterase activity and antioxidant propertiesRussian Chemical Bulletin, 2017
- 1,2,4-Thiadiazoles as promising multifunctional agents for treatment of neurodegenerative diseasesRussian Chemical Bulletin, 2016
- The influence of docosahexaenoic acid moiety on cytotoxic activity of 1,2,4-thiadiazole derivativesBiomeditsinskaya Khimiya, 2014
- Discovery of small molecule cancer drugs: Successes, challenges and opportunitiesMolecular Oncology, 2012
- Novel 1,2,4-thiadiazoles with an NO-producing fragmentDoklady Chemistry, 2010
- Diversity-oriented synthesis as a tool for the discovery of novel biologically active small moleculesNature Communications, 2010
- Selection criteria for drug‐like compoundsMedicinal Research Reviews, 2003
- Evolution of Anticancer Drug Discovery and the Role of Cell-Based ScreeningJNCI Journal of the National Cancer Institute, 2002